Epoxide hydrolases: Mechanisms, inhibitor designs, and biological roles

Christophe Morisseau, Bruce D. Hammock

Research output: Contribution to journalArticle

331 Citations (Scopus)

Abstract

Organisms are exposed to epoxide-containing compounds from both exogenous and endogenous sources. In mammals, the hydration of these compounds by various epoxide hydrolases (EHs) can not only regulate their genotoxicity but also, for lipid-derived epoxides, their endogenous roles as chemical mediators. Recent findings suggest that the EHs as a family represent novel drug discovery targets for regulation of blood pressure, inflammation, cancer progression, and the onset of several other diseases. Knowledge of the EH mechanism provides a solid foundation for the rational design of inhibitors, and this review summarizes the current understanding of the catalytic mechanism of the EHs. Although the overall EH mechanism is now known, the molecular basis of substrate selectivity, possible allosteric regulation, and many fine details of the catalytic mechanism remain to be solved. Finally, recent development in the design of EH inhibitors and the EH biological role are discussed.

Original languageEnglish (US)
Pages (from-to)311-333
Number of pages23
JournalAnnual Review of Pharmacology and Toxicology
Volume45
DOIs
StatePublished - 2005

Fingerprint

Epoxide Hydrolases
Epoxy Compounds
Allosteric Regulation
Mammals
Blood pressure
Drug Discovery
Hydration
Blood Pressure
Inflammation
Lipids
Substrates

Keywords

  • α/β-hydrolase fold family
  • Epoxy-eicosatrienoic acids
  • Hydroxyl-alkyl-enzyme intermediate
  • Hypertension
  • N,N′-dialkyl-ureas

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Epoxide hydrolases : Mechanisms, inhibitor designs, and biological roles. / Morisseau, Christophe; Hammock, Bruce D.

In: Annual Review of Pharmacology and Toxicology, Vol. 45, 2005, p. 311-333.

Research output: Contribution to journalArticle

Morisseau, Christophe ; Hammock, Bruce D. / Epoxide hydrolases : Mechanisms, inhibitor designs, and biological roles. In: Annual Review of Pharmacology and Toxicology. 2005 ; Vol. 45. pp. 311-333.
@article{002126532e5642059dbb13774c63876d,
title = "Epoxide hydrolases: Mechanisms, inhibitor designs, and biological roles",
abstract = "Organisms are exposed to epoxide-containing compounds from both exogenous and endogenous sources. In mammals, the hydration of these compounds by various epoxide hydrolases (EHs) can not only regulate their genotoxicity but also, for lipid-derived epoxides, their endogenous roles as chemical mediators. Recent findings suggest that the EHs as a family represent novel drug discovery targets for regulation of blood pressure, inflammation, cancer progression, and the onset of several other diseases. Knowledge of the EH mechanism provides a solid foundation for the rational design of inhibitors, and this review summarizes the current understanding of the catalytic mechanism of the EHs. Although the overall EH mechanism is now known, the molecular basis of substrate selectivity, possible allosteric regulation, and many fine details of the catalytic mechanism remain to be solved. Finally, recent development in the design of EH inhibitors and the EH biological role are discussed.",
keywords = "α/β-hydrolase fold family, Epoxy-eicosatrienoic acids, Hydroxyl-alkyl-enzyme intermediate, Hypertension, N,N′-dialkyl-ureas",
author = "Christophe Morisseau and Hammock, {Bruce D.}",
year = "2005",
doi = "10.1146/annurev.pharmtox.45.120403.095920",
language = "English (US)",
volume = "45",
pages = "311--333",
journal = "Annual Review of Pharmacology and Toxicology",
issn = "0362-1642",
publisher = "Annual Reviews Inc.",

}

TY - JOUR

T1 - Epoxide hydrolases

T2 - Mechanisms, inhibitor designs, and biological roles

AU - Morisseau, Christophe

AU - Hammock, Bruce D.

PY - 2005

Y1 - 2005

N2 - Organisms are exposed to epoxide-containing compounds from both exogenous and endogenous sources. In mammals, the hydration of these compounds by various epoxide hydrolases (EHs) can not only regulate their genotoxicity but also, for lipid-derived epoxides, their endogenous roles as chemical mediators. Recent findings suggest that the EHs as a family represent novel drug discovery targets for regulation of blood pressure, inflammation, cancer progression, and the onset of several other diseases. Knowledge of the EH mechanism provides a solid foundation for the rational design of inhibitors, and this review summarizes the current understanding of the catalytic mechanism of the EHs. Although the overall EH mechanism is now known, the molecular basis of substrate selectivity, possible allosteric regulation, and many fine details of the catalytic mechanism remain to be solved. Finally, recent development in the design of EH inhibitors and the EH biological role are discussed.

AB - Organisms are exposed to epoxide-containing compounds from both exogenous and endogenous sources. In mammals, the hydration of these compounds by various epoxide hydrolases (EHs) can not only regulate their genotoxicity but also, for lipid-derived epoxides, their endogenous roles as chemical mediators. Recent findings suggest that the EHs as a family represent novel drug discovery targets for regulation of blood pressure, inflammation, cancer progression, and the onset of several other diseases. Knowledge of the EH mechanism provides a solid foundation for the rational design of inhibitors, and this review summarizes the current understanding of the catalytic mechanism of the EHs. Although the overall EH mechanism is now known, the molecular basis of substrate selectivity, possible allosteric regulation, and many fine details of the catalytic mechanism remain to be solved. Finally, recent development in the design of EH inhibitors and the EH biological role are discussed.

KW - α/β-hydrolase fold family

KW - Epoxy-eicosatrienoic acids

KW - Hydroxyl-alkyl-enzyme intermediate

KW - Hypertension

KW - N,N′-dialkyl-ureas

UR - http://www.scopus.com/inward/record.url?scp=13844316739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13844316739&partnerID=8YFLogxK

U2 - 10.1146/annurev.pharmtox.45.120403.095920

DO - 10.1146/annurev.pharmtox.45.120403.095920

M3 - Article

C2 - 15822179

AN - SCOPUS:13844316739

VL - 45

SP - 311

EP - 333

JO - Annual Review of Pharmacology and Toxicology

JF - Annual Review of Pharmacology and Toxicology

SN - 0362-1642

ER -